New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)

Listen Now

Topics Covered

• Overview of Acute Lymphocytic/Lymphoblastic Leukemia (ALL) in Children
• Current Standard of Care, including Chemotherapy & New Treatment Approaches
• Treatment of Recurrent ALL
• Targeted Treatment & Stem Cell Transplantation
• The Role of Clinical Trials in Childhood ALL
• Managing Treatment Side Effects
• Follow-Up Exams
• Social & Emotional Issues During & After ALL Treatment
• Late & Long-Term Effects of ALL Treatment in Children
• Key Questions to Ask the Doctor and Health Care Team in Making Treatment Decisions
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Gabriel A. Robbins, MD

Pediatric Hematology-Oncology, Stephen D. Hassenfeld Children’s Center for Cancer & Blood Disorders, NYU Langone Health

Anna C. Muriel, MD

Chief, Division of Pediatric Psychosocial Oncology, Institute Physician, Dana-Farber Cancer Institute, Associate Professor of Psychiatry, Harvard Medical School

Carrie Callas

Director of Programs, Leukemia Research Foundation

Lauren Chatalian, MSW

Director of Advocacy, CancerCare

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on August 02, 2022.